Some biotech investors had probably never heard of exosomes until Codiak’s chief executive, Doug Williams, made his pitch at the JP Morgan conference two weeks ago. But the area has been gaining traction, and Jazz’s $56m up-front...
Read More »
Cambridge, MA – December 11, 2017 – Codiak POSITION DESCRIPTION Codiak BioSciences is a venture-backed start-up dedicated to harnessing the power of exosomes as both therapeutics and...
Read More »
Proceeds Will Carry First Drug Candidates Into Clinical Trials. Existing And New Investors Participate Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced the...
Read More »
Codiak Biosciences is seeking a Research Associate, Process Analytics to support the development of our novel exosome bioanalytical characterization platform. This is a unique opportunity to contribute experimentally, as well as intellectually, to the process development of a novel exosome ...
Read More »
Codiak Is Launched To Exploit The Exosome | Chemical … cen.acs.org/…/Codiak–Launched-Exploit-… Chemical & Engineering News 6 days ago – Looking to exploit a natural cellular communication highway, a new company, Codiak BioSciences, has launched with $80 million in venture … Codiak ...
Read More »
Codiak BioSciences Inc. announced today the closing of the first portion of a planned $80+ million Series A and B financing. The company also executed license and sponsored research agreements with The University of Texas MD Anderson Cancer Center in ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
